Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Chemello

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Lipidology|February 28, 2026
Lipoprotein(a) in familial hypercholesterolemiaAli K Jaafar, Steeve Bourane, Gilles C Lambert, et al.
Nature Reviews. Endocrinology|September 17, 2025
HDL metabolism and function in diabetes mellitusBlake J Cochran, Thomas W King, Kevin Chemello, et al.
Cardiovascular Diabetology|February 8, 2022
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetesMikaël Croyal, Matthieu Wargny, Kevin Chemello, et al.
International Journal of Molecular Sciences|December 24, 2021
A Systematic Approach to Assess the Activity and Classification of PCSK9 VariantsKepa B Uribe, Kevin Chemello, Asier Larrea-Sebal, et al.
Journal of Lipid Research|March 16, 2018
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot studyValentin Blanchard, Stéphane Ramin-Mangata, Stéphanie Billon-Crossouard, et al.
Journal of Lipid Research|October 9, 2022
A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In VivoAlexandra K Suchowerska, Geurt Stokman, James T Palmer, et al.
Journal of Lipid Research|May 15, 2020
A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteinsValentin Blanchard, Damien Garçon, Catherine Jaunet, et al.
Circulation. Genomic and Precision Medicine|February 8, 2022
Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular RiskStefan Coassin, Kevin Chemello, Ilya Khantalin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Lipidology|February 28, 2026
Lipoprotein(a) in familial hypercholesterolemiaAli K Jaafar, Steeve Bourane, Gilles C Lambert, et al.
Nature Reviews. Endocrinology|September 17, 2025
HDL metabolism and function in diabetes mellitusBlake J Cochran, Thomas W King, Kevin Chemello, et al.
Cardiovascular Diabetology|February 8, 2022
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetesMikaël Croyal, Matthieu Wargny, Kevin Chemello, et al.
International Journal of Molecular Sciences|December 24, 2021
A Systematic Approach to Assess the Activity and Classification of PCSK9 VariantsKepa B Uribe, Kevin Chemello, Asier Larrea-Sebal, et al.
Journal of Lipid Research|March 16, 2018
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot studyValentin Blanchard, Stéphane Ramin-Mangata, Stéphanie Billon-Crossouard, et al.
Journal of Lipid Research|October 9, 2022
A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In VivoAlexandra K Suchowerska, Geurt Stokman, James T Palmer, et al.
Journal of Lipid Research|May 15, 2020
A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteinsValentin Blanchard, Damien Garçon, Catherine Jaunet, et al.
Circulation. Genomic and Precision Medicine|February 8, 2022
Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular RiskStefan Coassin, Kevin Chemello, Ilya Khantalin, et al.
Pageof 1